头孢哌酮舒巴坦钠静脉滴注加雾化治疗老年慢性阻塞性肺疾病合并感染的临床疗效分析

发布时间：2019-03-14 07:58

【摘要】：目的探讨并分析在老年性慢性阻塞性肺疾病(慢阻肺)合并感染的临床治疗中头孢哌酮舒巴坦钠静脉滴注加雾化的治疗效果。方法选取江苏省大丰市第三人民医院内科2011年4月至2013年10月收治的老年慢阻肺合并感染的患者50例,采用随机分组的方式将其平均分成观察组和对照组,两组患者均行头孢哌酮舒巴坦钠静脉滴注治疗,观察组在此基础上加入雾化吸入治疗,系统治疗7d,对两组患者的治疗效果进行比对和分析。结果观察组患者症状缓解率为84%,明显高于对照组患者症状缓解率56%(P0.05);观察组患者的体温恢复时间为(2.23±1.9)d也要明显高于对照组患者的体温恢复时间(4.97±2.1)d(P0.05)。结论在老年慢阻肺合并感染的临床治疗中,头孢哌酮舒巴坦钠静脉滴注加雾化的治疗方法,临床效果显著,值得借鉴并推广。
[Abstract]:Objective to investigate and analyze the therapeutic effect of cefoperazone sulbactam sodium intravenous drip plus atomization in the treatment of senile chronic obstructive pulmonary disease (COPD) complicated with infection. Methods from April 2011 to October 2013, 50 elderly patients with chronic obstructive pulmonary disease complicated with infection were randomly divided into observation group and control group, who were treated in Dafeng third people's Hospital, Jiangsu Province, from April 2011 to October 2013, and divided them into two groups: observation group and control group. The patients in both groups were treated with cefoperazone sulbactam sodium intravenous drip. The observation group was treated with atomization inhalation for 7 days. The therapeutic effects of the two groups were compared and analyzed. Results the symptom remission rate in the observation group was 84%, which was significantly higher than that in the control group (56%) (P0.05). The recovery time of body temperature in observation group was (2.23 卤1.9) days, which was significantly higher than that in control group (4.97 卤2.1) d (P 0.05). Conclusion the clinical effect of cefoperazone sulbactam sodium plus atomization is significant in the clinical treatment of chronic obstructive pulmonary infection in the elderly, which is worthy of reference and popularization.
【作者单位】：江苏省大丰市第三人民医院内科;
【分类号】：R563.9

【参考文献】